Results 131 to 140 of about 558,994 (238)

Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment. [PDF]

open access: yesLung
Birring SS   +7 more
europepmc   +1 more source

Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.

open access: yesHealth Technol Assess
Snooks H   +18 more
europepmc   +1 more source

Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study.

open access: yesJMIR Res Protoc
Muhamad NA   +11 more
europepmc   +1 more source

Counteraction of Narcotic Antagonist Analgesics by the Narcotic Antagonist Naloxone

open access: yesExperimental Biology and Medicine, 1966
SummaryWhen the potent narcotic antagonist, naloxone, was injected subcutane-ously into mice and rats simultaneously with narcotic antagonist analgesics, naloxone counteracted the writhing test analgesic activity of the antagonists. Naloxone completely antagonized the potent analgesic activity of pentazocine, nalorphine, cyclazocine, and cy-clorphan ...
H. Blumberg, H. B. Dayton, P. Wolf
semanticscholar   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

An evaluation of naloxone as a narcotic antagonist in the dog.

Journal of the American Veterinary Medical Association, 1973
Naloxone hydrochloride, a synthetic narcotic antagonist, adequately reversed the effects of fentanyl (the narcotic component of a neuroleptanalgesic) and morphine sulfate in dogs.
Paddleford Rr, Short Ce
semanticscholar   +1 more source

Use of a narcotic antagonist (nalmefene) to suppress self-mutilative behavior in a stallion.

Journal of the American Veterinary Medical Association, 1988
Nalmefene, an opioid antagonist, caused a decrease in self-mutilative behavior in a 500-kg stallion. Self-mutilative attempts were counted during a control period and on 4 subsequent occasions after the IM administration of 100 mg, 200 mg, 400 mg, or 800
N. Dodman   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy